We are live on ! Find out more
SMIHU

Summit Healthcare Acquisition Corp. Units
SMIHU

Delisted

SMIHU was delisted on the 16th of March, 2023.

Back to rankings

16 hedge funds and large institutions have $45.2M invested in Summit Healthcare Acquisition Corp. Units in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

7% less capital invested

Capital invested by funds: $48.8M → $45.2M (-$3.58M)

11% less funds holding

Funds holding: 18 → 16 (-2)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.28%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
1
Increased
2
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$195K
2
UBS Group
UBS Group
Switzerland
+$2.94K
3
TRCT
Tower Research Capital (TRC)
New York
+$29

Top Sellers

Rank Fund Capital Flow
1
Calamos Advisors
Calamos Advisors
Illinois
-$2.85M
2
BCM
Basso Capital Management
Connecticut
-$975K
3
CSS
Cubist Systematic Strategies
Connecticut
-$290K
4
HIM
HGC Investment Management
Ontario, Canada
-$98.2K
5
Millennium Management
Millennium Management
New York
-$94K
Name Holding Trade Value Shares
Change 		Change in
Stake
BP
1
BFAM Partners
Hong Kong
$10.8M – – –
Jane Street
2
Jane Street
New York
$9.86M – – –
VAM
3
Valliance Asset Management
Hong Kong
$9.86M – – –
RI
4
RTW Investments
New York
$4.92M – – –
BCL
5
Bracebridge Capital LLC
Massachusetts
$4.58M – – –
CIM
6
Cowen Investment Management
New York
$1.97M – – –
SVI
7
Strategic Vision Investment
Hong Kong
$766K – – –
EC
8
Elequin Capital
New York
$739K – – –
Millennium Management
9
Millennium Management
New York
$493K -$94K -9,574 -16%
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
$413K +$195K +19,824 +90%
LP
11
LMR Partners
United Kingdom
$220K – – –
LCM
12
Landscape Capital Management
New Jersey
$197K – – –
CSS
13
Cubist Systematic Strategies
Connecticut
$194K -$290K -29,499 -60%
HIM
14
HGC Investment Management
Ontario, Canada
$99K -$98.2K -10,000 -50%
UBS Group
15
UBS Group
Switzerland
$9K +$2.94K +300 +45%
Calamos Advisors
16
Calamos Advisors
Illinois
– -$2.85M -292,080 Closed
BCM
17
Basso Capital Management
Connecticut
– -$975K -100,000 Closed
CS
18
Clear Street
New York
– -$2K -200 Closed
TRCT
19
Tower Research Capital (TRC)
New York
– +$29 +3 New

SMIHU Hedge Fund Activity: Q3 2022 in Review

16 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Summit Healthcare Acquisition Corp. Units (SMIHU) for Q3 2022, worth a combined $45.2M — down 7.3% from $48.8M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of SMIHU and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Susquehanna International Group, adding an estimated $195K. The largest seller was Calamos Advisors, exiting entirely with an estimated $2.85M sold.

  • 16 institutional investors held Summit Healthcare Acquisition Corp. Units (SMIHU) as of Q3 2022, down from 18 in Q2 2022.
  • Funds reported $45.2M of Summit Healthcare Acquisition Corp. Units stock for Q3 2022, down 7.3% quarter-over-quarter.
  • 1 fund opened new Summit Healthcare Acquisition Corp. Units positions in Q3 2022 and 3 closed out, a net change of -2 holders.
  • The largest Summit Healthcare Acquisition Corp. Units buyer in Q3 2022 was Susquehanna International Group, an estimated $195K added.
  • The largest Summit Healthcare Acquisition Corp. Units seller in Q3 2022 was Calamos Advisors, an estimated $2.85M sold.

Based on aggregated 13F filings for Q3 2022.